Medicure Inc. (OTCMKTS:MCUJF) Short Interest Update

Medicure Inc. (OTCMKTS:MCUJF) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totaling 7 shares, a decrease of 99.9% from the July 15th total of 5,660 shares. Based on an average trading volume of 4,968 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.

Medicure Stock Performance

OTCMKTS:MCUJF remained flat at $0.85 on Tuesday. The business has a fifty day moving average price of $0.76 and a 200-day moving average price of $0.81. The firm has a market cap of $8.87 million, a PE ratio of -1.81 and a beta of 0.99. Medicure has a 12-month low of $0.67 and a 12-month high of $0.97. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.03.

Medicure (OTCMKTS:MCUJF) last released its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01. The firm had revenue of $5.79 million during the quarter, compared to analyst estimates of $3.63 million. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.